Peptides DB
Research-centric peptide and protocol reference hub
Study 21 of 22Mazdutide (IBI362) literatureToxicology reports · Case report2026

Intravenous lipid emulsion as rescue therapy in severe quetiapine overdose: A case report.

This case suggests that intravenous lipid emulsion may be considered as a rescue therapy in severe quetiapine overdose when conventional measures fail, but further evidence is needed to establish its efficacy.

Read at Toxicology reportsAdd to compare

Where it sits

this study against the rest of the mazdutide (ibi362) corpus
5
Preclinical
9
Observational · this one
0
Open-label
1
Randomised
7
Reviews

Summary and findings

This case report describes a 25-year-old woman who intentionally ingested approximately 4.5 g of quetiapine and developed severe neurological deterioration and refractory distributive shock. A 20% intravenous lipid emulsion was administered as rescue therapy, leading to marked neurological improvement and hemodynamic stabilization within hours. No treatment-related adverse events were reported.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Glasgow Coma Scale score improved to 14/15 within three hours.n=12026

Abstract

The authors’ words, as Toxicology reports supplied them

Severe quetiapine overdose may lead to central nervous system depression and cardiovascular instability; however, refractory distributive shock is an uncommon and life-threatening presentation. Intravenous lipid emulsion has emerged as a potential adjunctive therapy in intoxications caused by highly lipophilic drugs, although evidence remains limited. We report the case of a 25-year-old woman with intentional ingestion of approximately 4.5 g of quetiapine, who developed progressive neurological deterioration and refractory distributive shock despite mechanical ventilation and dual vasopressor support. Laboratory findings showed severe metabolic acidosis with hyperlactataemia, and echocardiography revealed a hyperdynamic profile with reduced systemic vascular resistance. Given the persistence of haemodynamic instability and neurological impairment, a 20% intravenous lipid emulsion was administered as rescue therapy. Within three hours, the patient exhibited marked neurological improvement, with recovery of consciousness (Glasgow Coma Scale score 14/15), along with progressive haemodynamic stabilization allowing discontinuation of vasopressors. Lactate levels normalized within 9 h, and the patient was successfully extubated at 24 h, with no treatment-related adverse events. This case highlights the potential role of intravenous lipid emulsion as an adjunctive rescue therapy in severe quetiapine intoxication with refractory haemodynamic and neurological compromise. Although causality cannot be definitively established, the temporal association and rapid clinical response support its consideration when conventional supportive measures are insufficient.

Background

Severe quetiapine overdose can result in central nervous system depression and cardiovascular instability, with refractory distributive shock being a rare but critical outcome. Previous literature has suggested that intravenous lipid emulsion may serve as an adjunctive therapy for overdoses involving lipophilic drugs, although the evidence supporting its efficacy is limited. This case report aims to provide insight into the potential role of intravenous lipid emulsion in such scenarios.

Methods

This is a case report of a 25-year-old woman who ingested approximately 4.5 g of quetiapine. The patient developed neurological deterioration and refractory distributive shock despite mechanical ventilation and dual vasopressor support. A 20% intravenous lipid emulsion was administered as rescue therapy, and outcomes were monitored over a period of hours.

Results

The administration of 20% intravenous lipid emulsion resulted in a Glasgow Coma Scale score improvement to 14/15 within three hours. Lactate levels normalized within 9 hours, and the patient was extubated successfully at 24 hours. No treatment-related adverse events were reported.

Interpretation

While the rapid clinical response following the administration of intravenous lipid emulsion is noteworthy, it is essential to recognize that this is a single case report and does not provide definitive evidence of causality. The improvement in neurological status and hemodynamic stability may be attributed to the lipid emulsion, but confounding factors such as concurrent supportive measures cannot be ruled out. Further studies are needed to validate these findings and assess the clinical significance of intravenous lipid emulsion in severe quetiapine overdose.

Key findings

  • Approximately 4.5 g of quetiapine ingested.
  • Glasgow Coma Scale score improved to 14/15 within three hours.
  • Lactate levels normalized within 9 hours.
  • Patient successfully extubated at 24 hours.

Limitations

  • Single case report limits generalizability.
  • Causality cannot be definitively established.
  • No control group for comparison.

Elsewhere in the Mazdutide (IBI362) corpus

CHighly efficient production of <i>β</i>-caryophyllene in <i>Saccharomyces cerevisiae</i> using a novel synthase from <i>Artemisia argyi</i>.Synthetic and systems biotechnology · 2026 · Final β-caryophyllene titer of 35.4 g/L.In vitroBHomocysteine, cysteine and methionine are associated with 90-day prognosis in intracerebral hemorrhage patients.Annals of medicine · 2026 · n=212 · AUC = 0.819HumanCA Postprocessing Software Tool for 1H and 31P MRI Data Analysis.Topics in magnetic resonance imaging : TMRI · 2026 · Not reported in abstract.AnimalDEfficacy and Safety of Mazdutide for Type 2 Diabetes: a GRADE assessed systematic review and meta-analysis of randomized controlled trialsbiorxiv-preprint · 2026 · MD −1.53%; 95% CI −1.70 to −1.35 for HbA1c reduction compared to placebo.reviewCSingle-cell transcriptome-guided biomimetic magnetothermal hydrogel microspheres for multimodal eradication of residual glioblastoma.Bioactive materials · 2026 · Tumor volume reduced to approximately 5% of controls.AnimalCIntegrative multi-omics analysis identifies VCAN and ESM1 as candidate cell-type-associated biomarkers of NET-related glomerular injury in diabetic kidney disease.Renal failure · 2026 · Not reported in abstract.Animal